SCD Is >3 Times More Prevalent Than Other Rare Inherited Disorders



1. Centers for Disease Control and Prevention. Data & Statistics: Sickle cell disease. Accessed July 1, 2020. 2. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512-S521. 3. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: Final data for 2017. National Vital Health Statistics Reports; 67:8. Hyattsville, MD: National Center for Health Statistics; 2018. 4. NORD. Huntington’s disease. Accessed July 1, 2020. 5. Cystic Fibrosis Foundation. Patient Registry 2018 Annual Data Report. Accessed July 1, 2020. 6. Becker muscular dystrophy. Accessed July 1, 2020. 7. Centers for Disease Control and Prevention. Hemophilia. Accessed July 1, 2020. 8. Adams-Graves P, Bronte-Jordan L. Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence. Expert Rev Hematol. 2016;9(6):541-542. 9. Arias E, Rostron BL, Tejada-Vera B. United States life tables, 2005. National Vital Health Statistics Reports; 58:10. Hyattsville, MD: March 3, 2010. 10. Lanzkron S, Carroll CP, Haywood C. Mortality rates and age at death from sickle cell disease: US, 1979-2005. Public Health Rep. 2013;128(2):110-116. 11. Pleasants S. Epidemiology: a moving target. Nature. 2014;515(7526):S2-S3. 12. National Institutes of Health. National Heart, Lung, and Blood Institute. A Century of Progress: Milestones in Sickle Cell Disease Research and Care. No. 2015; 2015;10-7657. September 2010. 13. Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015(1):160-167. doi: 10.1182/asheducation-2015.1.160. PMID: 26637716; PMCID: PMC4697437.

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2021 Novartis Pharmaceuticals Corporation. All rights reserved.

1/21 SDC-1236447